Literature DB >> 14703084

Evaluation of deficiencies in labeling of commercial probiotics.

J Scott Weese1.   

Abstract

Labels of 44 human or veterinary probiotics were scrutinized. Organisms were improperly identified in 9/21 (43%) human and 8/23 (35%) veterinary products. Contents of 5/20 (25%) human and 3/17 (18%) veterinary products were misspelled. In only 9 human and 2 veterinary products were the contents adequately identified.

Entities:  

Mesh：

Year:  2003        PMID： 14703084      PMCID： PMC340366     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  10 in total

1.  Microbiologic evaluation of commercial probiotics.

Authors:  J Scott Weese
Journal:  J Am Vet Med Assoc       Date:  2002-03-15       Impact factor: 1.936

2.  Deficiencies in microbiological quality and labelling of probiotic supplements.

Authors:  J M T Hamilton-Miller; S Shah
Journal:  Int J Food Microbiol       Date:  2002-01-30       Impact factor: 5.277

Review 3.  Enterococci at the crossroads of food safety?

Authors:  C M Franz; W H Holzapfel; M E Stiles
Journal:  Int J Food Microbiol       Date:  1999-03-01       Impact factor: 5.277

4.  Probiotics.

Authors:  F Guarner; G J Schaafsma
Journal:  Int J Food Microbiol       Date:  1998-02-17       Impact factor: 5.277

5.  Probiotic Enterococcus faecium strain is a possible recipient of the vanA gene cluster.

Authors:  B Lund; C Edlund
Journal:  Clin Infect Dis       Date:  2001-04-13       Impact factor: 9.079

6.  Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin.

Authors:  B Lund; C Edlund; L Barkholt; C E Nord; M Tvede; R L Poulsen
Journal:  Scand J Infect Dis       Date:  2000

7.  Preliminary investigation of the probiotic potential of Lactobacillus rhamnosus strain GG in horses: fecal recovery following oral administration and safety.

Authors:  J Scott Weese; Maureen E C Anderson; Andrew Lowe; Gabrielle J Monteith
Journal:  Can Vet J       Date:  2003-04       Impact factor: 1.008

8.  A microbiology investigation on probiotic pharmaceutical products used for human health.

Authors:  F Canganella; S Paganini; M Ovidi; A M Vettraino; L Bevilacqua; S Massa; L D Trovatelli
Journal:  Microbiol Res       Date:  1997-07       Impact factor: 5.415

9.  Microbiologic characteristics of Lactobacillus products used for colonization of the vagina.

Authors:  V L Hughes; S L Hillier
Journal:  Obstet Gynecol       Date:  1990-02       Impact factor: 7.661

10.  Preliminary evaluation of Lactobacillus rhamnosus strain GG, a potential probiotic in dogs.

Authors:  J Scott Weese; Maureen E C Anderson
Journal:  Can Vet J       Date:  2002-10       Impact factor: 1.008
  10 in total
  10 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Assessment of commercial probiotic bacterial contents and label accuracy.

Authors:  J Scott Weese; Hayley Martin
Journal:  Can Vet J       Date:  2011-01       Impact factor: 1.008

3.  PrimiOtic and PrimiOtic Plus: novel probiotic for primates suffering from idiopathic chronic diarrhea.

Authors:  Jaime L Lecker; Karen Froberg-Fejko
Journal:  Lab Anim (NY)       Date:  2015-10       Impact factor: 12.625

Review 4.  The microbiome and probiotics in childhood.

Authors:  Michael Harrison Hsieh
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

5.  The human microbiome and probiotics: implications for pediatrics.

Authors:  Michael H Hsieh; James Versalovic
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2008 Nov-Dec

6.  Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group.

Authors:  Sophie Coudeyras; Hélène Marchandin; Céline Fajon; Christiane Forestier
Journal:  Appl Environ Microbiol       Date:  2008-03-07       Impact factor: 4.792

7.  Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders.

Authors:  Theodoros Kelesidis; Charalabos Pothoulakis
Journal:  Therap Adv Gastroenterol       Date:  2012-03       Impact factor: 4.802

Review 8.  Probiotic use in horses - what is the evidence for their clinical efficacy?

Authors:  A Schoster; J S Weese; L Guardabassi
Journal:  J Vet Intern Med       Date:  2014-09-17       Impact factor: 3.333

9.  Probiotics for vaginal health in South Africa: what is on retailers' shelves?

Authors:  Anna-Ursula Happel; Shameem Z Jaumdally; Tanya Pidwell; Tracy Cornelius; Heather B Jaspan; Remy Froissart; Shaun L Barnabas; Jo-Ann S Passmore
Journal:  BMC Womens Health       Date:  2017-01-19       Impact factor: 2.809

10.  Design of PCR assays to specifically detect and identify 37 Lactobacillus species in a single 96 well plate.

Authors:  Eiseul Kim; Seung-Min Yang; Bora Lim; Si Hong Park; Bryna Rackerby; Hae-Yeong Kim
Journal:  BMC Microbiol       Date:  2020-04-15       Impact factor: 3.605
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.